APOE2 promotes longevity independent of Alzheimer’s disease
Authors:
- Mitsuru ShinoharaMSMitsuru Shinohara
- Takahisa KanekiyoTKTakahisa Kanekiyo
- Masaya TachibanaMTMasaya Tachibana
- Aishe KurtiAKAishe Kurti
- Yuan FuYFYuan Fu
- Jing ZhaoJZJing Zhao
- Xianlin HanXHXianlin Han
- Patrick M. SullivanPSPatrick M. Sullivan
- William G RebeckWRWilliam G Rebeck
- John D. FryerJFJohn D. Fryer
- Michael G. HeckmanMHMichael G. Heckman
Preprint
Abstract
Objective: Although apolipoprotein E ( APOE ) allele associates with longevity, its mechanism is not understood. The protective effects of APOE 2 and the deleterious effects of APOE4 on Alzheimer’s disease (AD) risk may confound APOE effects on longevity. Methods: We analyzed a large number of subjects from the National Alzheimer’s Coordinating Center (NACC), and animal models expressing human apoE isoforms in the absence of AD. Results: Clinically, the APOE2 allele was associated with longer lifespan, while APOE4 associated with shorter lifespan, compared to the common APOE3 allele. This effect was also seen irrespective of clinical AD status, and in subjects with little amyloid pathology or after adjustment for AD-related pathologies. In animal studies, apoE2-TR mice also exhibited longer lifespan, while apoE4 showed some trends of shorter lifespan. Notably, old apoE2-TR mice kept activity measured by open field assay, associated with longer lifespan. Evidence of preserved activity in APOE2 carrier was also obtained in clinical records. In animal studies, higher levels of apoE2 in brain and plasma were correlated with activity. Moreover, lower levels of total cholesterol in the brain and higher levels of high-density lipoprotein cholesterol and triglycerides in the plasma of apoE2-TR mice were associated with apoE levels and more activity. Interpretation: APOE2 can contribute to longevity independent of AD. Preserved activity would be an early-observable feature of apoE2-mediated longevity, where higher levels of apoE2 and its-associated lipid metabolism might be involved.Keywords
This publication has 33 references indexed in Scilit:
- APOEAlleles and Extreme Human LongevityThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2018
- Alzheimer's Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain FunctionCurrent Alzheimer Research, 2016
- APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluationsAnnals of Neurology, 2016
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyNature Reviews Neurology, 2013
- A genome-wide association study confirms APOE as the major gene influencing survival in long-lived individualsMechanisms of Ageing and Development, 2011
- Genome‐wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisitedAging Cell, 2011
- APOE-related mortality: Effect of dementia, cardiovascular disease and genderNeurobiology of Aging, 2009
- Apolipoprotein E Genotype Determines Survival in the Oldest Old (85 Years or Older) Who Have Good CognitionArchives of Neurology, 1996
- Genetic associations with human longevity at the APOE and ACE lociNature Genetics, 1994
- Apo E allele frequencies in younger (age 42–50) vs older (age 65–90) womenGenetic Epidemiology, 1993